The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS).
K. Krzemieniecki
No relevant relationships to disclose
S. AntolĂ­n Novoa
No relevant relationships to disclose
M. Gozy
No relevant relationships to disclose
C. Schumacher
No relevant relationships to disclose
G. G. Steger
Honoraria - Cephalon
G. Carteni'
No relevant relationships to disclose
B. R. Bird
Research Funding - Cephalon
Other Remuneration - Cephalon
E. Albuisson
Consultant or Advisory Role - Cephalon
A. Barnadas
No relevant relationships to disclose
G. Batist
No relevant relationships to disclose
J. De Mouzon
Consultant or Advisory Role - Cephalon
F. Erdkamp
Research Funding - Cephalon
R. C. F. Leonard
Consultant or Advisory Role - Cephalon
H. Lueck
No relevant relationships to disclose
M. Namer
Honoraria - Amgen; Sanofi
M. Venturini
No relevant relationships to disclose
P. Ronga
Employment or Leadership Position - Cephalon
S. Maumus-Robert
Consultant or Advisory Role - Cephalon
M. S. Aapro
Consultant or Advisory Role - Cephalon
Honoraria - Cephalon